EUGENE DURENARD PHD
Business Development Advisor
Eugene is Founder and CEO of Hyperbolic Holdings, a Swiss-based holding, management consulting and strategy advisory company specialized in healthcare. Eugene has an investment and entrepreneurial experience spanning 20 years. For the last 7 years he has been working with family offices on direct investments and philanthropy focused on life sciences. He serves on the advisory board of several private companies in the biotech and medtech sectors as well as an impact venture fund focused on healthcare. After an initial career in proprietary research and trading at Saloman Brothers and Credit Suisse in London, he co-founded Orion Investment Management in Bermuda specializing in quantitative asset and liability management for institutions and private clients. He subsequently sold it to Capital G Bank and co-headed their asset management. Eugene spent several years establishing personal connections with representatives of 40+ clusters of life science innovation, families operating healthcare businesses and industry leaders globally. He regularly visits labs and incubators, meets with leading scientists and innovators in order to keep abreast of current trends and developments. He has a PhD in Mathematics from Harvard University.
JOSEPH COOPER MBA
Mr. Cooper is a skilled pharmaceutical corporate development and operations executive with significant experience in building value through development and execution of corporate partnering transactions as well as building growth companies. He currently serves a Chief Business Officer for Pangolin Health, a company focused on wastewater-based epidemiology and also serves a Chief of Corporate Development for Resonea, Inc, a digital health company. Mr. Cooper has previously served in executive level business development and operational roles including Executive Vice President of Medicis Pharmaceutical Corporation, a NYSE based specialty pharmaceutical company where he was responsible for all corporate development and product development operations including serving on the executive committee. Mr. Cooper also served as general manager for an orphan drug business, Ucycled Pharma, and has an excellent understanding of value creation within the healthcare industry including significant relationships within the corporate and investor community. Mr. Cooper holds an undergraduate degree from Northeastern Illinois University and a master’s in business administration (MBA) from the WP Carey School at Arizona State University.